Kostis Gyftopoulos

Prof. Dr. Kostis Gyftopoulos

Department of Anatomy, University of Patras School of Medicine, Rion, 26504 Patras, Greece
+2
orcid
Urologic Surgeon, Professor in Clinical and Surgical Anatomy...

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in Cancers
Verified
Journal Article
Open access
PDF file
SPSofia Papanikolaou
Sofia Papanikolaou
AVAikaterini Vourda
Aikaterini Vourda
SSSpyros Syggelos
Spyros Syggelos
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
Prostate cancer, the second most common malignancy in men, is characterized by high heterogeneity that poses several therapeutic challenges. Epithelial–mesenchymal transition (EMT) is a dynamic, reversible cellular process which is essential in normal embryonic morphogenesis and wound healing. However, the cellular changes that are induced by EMT suggest that it may also play a central role in tumor progression, invasion, metastasis, and resistance to current therapeutic options. These changes include enhanced motility and loss of cell–cell adhesion that form a more aggressive cellular phenotype. Moreover, the reverse process (MET) is a necessary element of the metastatic tumor process. It is highly probable that this cell plasticity reflects a hybrid state between epithelial and mesenchymal status. In this review, we describe the underlying key mechanisms of the EMT-induced phenotype modulation that contribute to prostate tumor aggressiveness and cancer therapy resistance, in an effort to provide a framework of this complex cellular process.

Verified
Journal Article
Open access
PDF file
IGIoanna Maria Grypari
Ioanna Maria Grypari
VTVasiliki Tzelepi
Vasiliki Tzelepi
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
Prostate cancer (PCa) has a distinct molecular signature, including characteristic chromosomal translocations, gene deletions and defective DNA damage repair mechanisms. One crucial pathway involved is homologous recombination deficiency (HRD) and it is found in almost 20% of metastatic castrate-resistant PCa (mCRPC). Inherited/germline mutations are associated with a hereditary predisposition to early PCa development and aggressive behavior. BRCA2, ATM and CHECK2 are the most frequently HRD-mutated genes. BRCA2-mutated tumors have unfavorable clinical and pathological characteristics, such as intraductal carcinoma. PARP inhibitors, due to the induction of synthetic lethality, have been therapeutically approved for mCRPC with HRD alterations. Mutations are detected in metastatic tissue, while a liquid biopsy is utilized during follow-up, recognizing acquired resistance mechanisms. The mismatch repair (MMR) pathway is another DNA repair mechanism implicated in carcinogenesis, although only 5% of metastatic PCa is affected. It is associated with aggressive disease. PD-1 inhibitors have been used in MMR-deficient tumors; thus, the MMR status should be tested in all metastatic PCa cases. A surrogate marker of defective DNA repair mechanisms is the tumor mutational burden. PDL-1 expression and intratumoral lymphocytes have ambivalent predictive value. Few experimental molecules have been so far proposed as potential biomarkers. Future research may further elucidate the role of DNA damage pathways in PCa, revealing new therapeutic targets and predictive biomarkers.

1 January 2014 in Urology Annals
Verified
Journal Article
Open access
PDF file
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
LILilis Ioannis
Lilis Ioannis
KHKourea Helen
Kourea Helen
PHPapadaki Helen
Papadaki Helen
Aim: To evaluate the expression of two different lymphatic vascular density (LVD) markers (D2-40 and LYVE-1) and a lymphangiogenic cytokine (Vascular Endothelial Growth Factor-C, [VEGF-C]) in prostate carcinoma and to investigate their relationship with the lymph node status. Settings and Design: Archival material study of 92 non-consecutive radical prostatectomy specimens. Materials and Methods: The mean LVD was assessed immunohistochemically in 24 prostate carcinoma specimens from patients with clinically localized disease, who were found to have nodal metastasis (pN1), and was compared with 68 pN0 cases. Furthermore, the mean LVD, VEGF-C expression, and lymphatic invasion were examined in relation to lymph node involvement. Results: Peritumoral (but not intratumoral) mean LVD assessed by D2-40 was higher in pN1 tumors (P = 0.015). LYVE-1 expression was limited and not associated with lymph node status. The VEGF-C expression was higher in the N1 cases and also correlated with the increased mean LVD in both the peri- and intratumoral compartments. Lymphatic invasion was strongly associated with nodal metastasis and higher VEGF-C expression. Conclusions: Our results indicate that increased peritumoral (but not intratumoral) LVD in the tumor specimen is associated with lymph node metastasis. Increased expression of VEGF-C is associated with higher LVD (in both intratumoral and peritumoral compartments) and with positive lymph node status, indicating a possible dual role in both lymphangiogenesis and lymphatic vessel invasion.

2 July 2018 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
MMMiltos Matkaris
Miltos Matkaris
AVAikaterini Vourda
Aikaterini Vourda
GSGeorge Sakellaropoulos
George Sakellaropoulos

1 June 2000 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
PPP. Perimenis
P. Perimenis
GSG. Sotiropoulou-Bonikou
G. Sotiropoulou-Bonikou
GSGeorge Sakellaropoulos
George Sakellaropoulos
IVI. Varakis
I. Varakis
GBG.A. Barbalias
G.A. Barbalias

1 January 2012 in Urology Annals
Verified
Journal Article
Open access
PDF file
Kostis GyftopoulosKostis Gyftopoulos
Kostis Gyftopoulos
Background and Objectives : A variety of surgical procedures of the penis can be performed under local anesthesia. We evaluated the efficacy and safety of EMLA cream anesthetic in such procedures. Materials and Methods : In total 330 adult patients were subjected to minor penile surgery including: Complete circumcision (73), short frenulum plasty (168), meatotomy (14), fulguration of penile warts (56) and fulguration of urethral (meatal) warts (19). The level of anesthesia obtained by EMLA cream application along with any adverse effects was recorded. Results: The use of EMLA on mucosal lesions provided excellent level of local anesthesia in almost all patients (245/246, 99.5%). Anesthesia of skin lesions was in part influenced by the site of application. Circumcision patients showed the lowest efficacy of the EMLA cream as the majority (~80%) required some form of further anesthesia until the completion of the procedure. No significant adverse effects were noted. A transient erythema was present in almost all mucosal applications. Conclusions: The topical anesthetic EMLA cream is a useful, efficient and safe tool for minor surgical procedures of the penis at the office setting, with the exception of circumcision, where an additional type of anesthesia is likely to be necessary. Side effects can be kept to a minimum when the suggested doses are respected (especially at mucosal application) and the time allowed for action is carefully tailored to the site of application and the type of procedure.